ReviewPharmaceutics2021

Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States.

Marion Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.